statistiche ricercatore

Continente	#
NA - Nord America	679
EU - Europa	297
AS - Asia	261
Continente sconosciuto - Info sul continente non disponibili	57
SA - Sud America	19
AF - Africa	7
OC - Oceania	1
Totale	1.321

Nazione	#
US - Stati Uniti d'America	655
SG - Singapore	114
IT - Italia	112
CN - Cina	55
IE - Irlanda	34
VN - Vietnam	32
RU - Federazione Russa	30
SE - Svezia	29
IN - India	19
CA - Canada	16
DE - Germania	16
BR - Brasile	15
GB - Regno Unito	15
UA - Ucraina	15
TR - Turchia	14
FI - Finlandia	8
PL - Polonia	7
ES - Italia	6
HK - Hong Kong	6
BE - Belgio	5
BD - Bangladesh	4
CZ - Repubblica Ceca	4
FR - Francia	4
JP - Giappone	4
NL - Olanda	4
PT - Portogallo	3
ZA - Sudafrica	3
CR - Costa Rica	2
HN - Honduras	2
MX - Messico	2
PK - Pakistan	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
AU - Australia	1
CL - Cile	1
CO - Colombia	1
CW - ???statistics.table.value.countryCode.CW???	1
DZ - Algeria	1
EC - Ecuador	1
EE - Estonia	1
EG - Egitto	1
ET - Etiopia	1
GD - Grenada	1
HR - Croazia	1
ID - Indonesia	1
JM - Giamaica	1
JO - Giordania	1
KH - Cambogia	1
KR - Corea	1
KZ - Kazakistan	1
LT - Lituania	1
PH - Filippine	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TN - Tunisia	1
TW - Taiwan	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	1.265

Nome	#
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma	198
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation	180
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking	173
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro	168
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study	167
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs	154
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome	138
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer	128
Synthesis, Biological Evaluation, and Computational Study of Pyridine- and Indazole-Based Inhibitors of the Inducible Nitric Oxide Synthase as Promising Antipsoriatic Agents	15
Totale	1.321

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	43	0	0	0	0	1	2	1	2	5	0	9	23
2022/2023	180	12	29	17	25	15	28	8	15	17	2	10	2
2023/2024	75	4	4	9	6	7	21	11	1	0	5	0	7
2024/2025	211	8	46	28	4	5	13	30	15	11	11	33	7
2025/2026	425	27	7	40	71	88	20	63	17	36	26	23	7
2026/2027	112	6	21	22	40	23	0	0	0	0	0	0	0
Totale													1.321